HEADACHE RELIEF 250 mg/1
ACETAMINOPHEN-ASPIRIN-CAFFEINE · TABLET, COATED · TARGET CORPORATION
HEADACHE RELIEF is a tablet, coated containing acetaminophen-aspirin-caffeine at 250 mg/1, taken oral. Manufactured by TARGET CORPORATION.
Key Facts
- Brand Name
- HEADACHE RELIEF
- Generic Name
- ACETAMINOPHEN-ASPIRIN-CAFFEINE
- NDC Code (Product)
11673-070- Manufacturer
- TARGET CORPORATION
- Strength
- 250 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- M013
- Drug Class
- Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
- Marketing Start
- 10/04/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is HEADACHE RELIEF used for?
HEADACHE RELIEF contains ACETAMINOPHEN-ASPIRIN-CAFFEINE. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is HEADACHE RELIEF a controlled substance?
HEADACHE RELIEF is not classified as a controlled substance by the DEA.
What is the generic name for HEADACHE RELIEF?
The generic name for HEADACHE RELIEF is ACETAMINOPHEN-ASPIRIN-CAFFEINE. There are no other listed brand versions of ACETAMINOPHEN-ASPIRIN-CAFFEINE.
What is the NDC code for HEADACHE RELIEF 250 mg/1?
The NDC (National Drug Code) for HEADACHE RELIEF 250 mg/1 is 11673-070, listed by TARGET CORPORATION.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)